Vimarsana
Biggest News Aggregation in the World

Page 2 - Session Display Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Session Display Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Session Display Date Today - Breaking & Trending Today

Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress - Vimarsana News

Allogene Therapeutics Announces Encore Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the European Hematology Association (EHA) Hybrid Congress

Published: May 11, 2023

Data Will Also Be Presented in a Poster Session at the American Society of Clinical Oncology Annual Meeting on June 3, 2023 SOUTH SAN FRANCISCO, Calif., May 11, 2023 -- Allogene Therapeutics,... | May 11, 2023

Source: marketscreener.com
Related Topics:
United StatesChristine CassianoAllogene AlloJavier MunozAmerican Society Of Clinical OncologyCongress OnLymphoma Program At Mayo ClinicEuropean Hematology AssociationDrug AdministrationAllogene Therapeutics IncData Will Also Be PresentedPoster SessionAmerican SocietyClinical OncologyAnnual MeetingHybrid CongressDurable Responses AchievedRefractory Largeb Cell LymphomaLymphoma ProgramMayo ClinicSession Display DateRegenerative Medicine Advanced TherapySouth San FranciscoForward Looking StatementsPrivate Securities Litigation Reform Act
AGENUS INC. : Stock Market News and Information | AGEN| US00847G7051 - Vimarsana News

AGENUS INC. : Stock Market News and Information | AGEN| US00847G7051

Published: April 26, 2023

AGENUS INC. : News, information and stories for AGENUS INC. | Nasdaq: AGEN | Nasdaq

Source: marketscreener.com
Related Topics:
United StatesBreelyn WilkyClinical ResearchUniversity Of Colorado MedicineAmerican Society Of Clinical OncologyMary Crowley Cancer ResearchAmerican SocietyClinical OncologySarcoma Medical OncologyDeputy Associate DirectorColorado MedicineOral Abstract SessionAntibody DesignedAvoid HepatoxicityAdvanced Solid TumorsMinal BarveExecutive Medical DirectorChief Medical OfficerDiscussion SessionDevelopmental TherapeuticsSession Display DateDiscussion Session DateAgenus IncStock ExchangeRegulatory News
New Data from Interim Analysis of Verastem Oncology's RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at the American Society of Clinical Oncology Annual Meeting - Vimarsana News

New Data from Interim Analysis of Verastem Oncology's RAMP 201 Trial Evaluating Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be Presented at the American Society of Clinical Oncology Annual Meeting

Published: April 26, 2023

Registration-Directed RAMP-201 Trial Designed to Address High Unmet Need in Low-Grade Serous Ovarian Cancer, a Unique and Distinct Type of Ovarian Cancer with Limited Treatment Options ... | April 26, 2023

Source: marketscreener.com
Related Topics:
United StatesBrian StuglikSusana BanerjeeExchange CommissionDrug AdministrationAmerican Society Of Clinical OncologyChugai Pharmaceutical Co LtdSecura Bio IncInstitute Of Cancer ResearchRaf And Mek ProgramVerastem OncologyPoster Discussion SessionAmerican SocietyClinical OncologyAnnual MeetingChief Executive OfficerCancer ResearchRoyal MarsdenGynecologic CancerSession Display DateDiscussion Session DateBoard NumberLow Grade Serous Ovarian CancerBreakthrough TherapySecura Bio
Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Published: April 26, 2023

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

Source: prnewswire.com
Related Topics:
United StatesLee CranmerAadi BiosciencesGopa IyerPrnewswire Aadi Bioscience IncMemorial Sloan Kettering Cancer CenterAadi Bioscience IncCompany Annual Report On FormFred Hutch Cancer CenterClinical Research Excluding TrialsInvestigator InitiatedPoster SessionMolecularly Targeted AgentsMemorial Sloan Kettering CancerSession Display DateBoard NumberDiscussion Session DateClinical Research ExcludingPoster Discussion SessionFred Hutch CancerMeeting Following AadiAadi BioscienceForward Looking StatementsPrivate Securities Litigation Reform ActAnnual Report